UAE sets a precedent for region’s longevity sector

• ‘Life Sciences in the UAE’ report by Sharjah Research Technology and Innovation Park (SRTIP) and Deep Knowledge Analytics (DKA) revealed
• UAE second globally with highest number of government and private hospitals accredited by JCI in the US, or Australian and Canadian accreditation bodies
• UAE third in registering the most innovation drugs, speeding up innovative medicines provisions and supporting medical tourism
• UAE longevity market surpassed $19 billion in 2020; projected to reach $32 billion by 2026

United Arab Emirates – March 30, 2022: The UAE is the second country after the US with the highest number of government and private hospitals accredited by either the Joint Commission International in the US, or Australian and Canadian accreditation bodies.

The UAE is also third after the Food and Drug Administration (FDA) and European Medicines Agency (EMA) in registering the most innovation drugs, expediting the process of providing innovative medicines and supporting medical tourism